relatlimab (BMS-986016) - BMS
Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
Libtayo (cemiplimab-rwlc) - Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42794996
 
Andrzej Ciborek; Dariusz Kowalczyk; Hanna Krauss; Jolanta Jaworek; Pawel Antoni Kolodziejski
 
Sep 27, 2026
 
Prev Next